Cellectar Biosciences Receives European Medicines Agency
The EMA’s PRIME status is granted to drug candidates that may offer a major therapeutic advantage over existing treatments, or benefit patients without...
Source: globenewswire.com
Page 2 - Monique Kosse News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Monique Kosse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Monique Kosse Today - Breaking & Trending Today
Cellectar Biosciences Announces Closing of up to Approximately $103 Million Private Placement Financing - Cellectar Biosciences (NASDAQ:CLRB)
FLORHAM PARK, N.J., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted
Source: benzinga.com
Aspira Women's Health Signs Exclusive Sample Procurement Agreement with The University of Oxford
Samples to be used in validating the Company’s EndoCheckSM test in development for the diagnosis of endometriosisAUSTIN, Texas, Aug. 31, 2023 (G...
Source: businessinsider.com
Aspira Women's Health Announces Michelle Snider as Senior Vice President, Commercial Strategy and Operations
AUSTIN, Texas, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc.(“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company f...
Source: businessinsider.com
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update
EscharEx® Phase III study protocol:FDA/EMA-aligned; patient enrollment commencing early 2024; two key research collaborations with wound industry ...
Source: businessinsider.com